These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9684812)

  • 1. Recurrent thromboembolism in two unrelated patients with double heterozygosity for factor V R506Q and factor II 20210G/A mutations.
    Veyradier A; Wolf M; Boyer-Neumann C; Parent F; Simonneau G; Meyer D
    Thromb Haemost; 1998 Jul; 80(1):201-2. PubMed ID: 9684812
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
    Yilmazer M; Kurtay G; Sonmezer M; Akar N
    Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation.
    Prandoni P; Tormene D; Spiezia L; Pesavento R; Simioni P
    J Thromb Haemost; 2008 Dec; 6(12):2223-4. PubMed ID: 18983490
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation in subjects carrying factor V Leiden or factor II A20210 mutations.
    Grandone E; Martinelli I; Margaglione M; Dragani A; Davì G
    J Thromb Haemost; 2006 Nov; 4(11):2496-8. PubMed ID: 17059474
    [No Abstract]   [Full Text] [Related]  

  • 7. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.
    Margaglione M; D'Andrea G; Colaizzo D; Cappucci G; del Popolo A; Brancaccio V; Ciampa A; Grandone E; Di Minno G
    Thromb Haemost; 1999 Dec; 82(6):1583-7. PubMed ID: 10613638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
    Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
    Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
    Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin gene.
    Brown K; Luddington R; Williamson D; Baker P; Baglin T
    Br J Haematol; 1997 Sep; 98(4):907-9. PubMed ID: 9326187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use.
    Legnani C; Palareti G; Guazzaloca G; Cosmi B; Lunghi B; Bernardi F; Coccheri S
    Eur Heart J; 2002 Jun; 23(12):984-90. PubMed ID: 12069454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of Factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes].
    Alvarez A; Barroso A; Robledo M; Arranz E; Outeiriño J; Benítez J
    Sangre (Barc); 1999 Feb; 44(1):7-12. PubMed ID: 10323090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden and prothrombin gene 20210A variant in neonatal thromboembolism and in healthy neonates and adults: a study in a single center.
    Atasay B; Arsan S; Günlemez A; Kemahli S; Akar N
    Pediatr Hematol Oncol; 2003 Dec; 20(8):627-34. PubMed ID: 14578033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombotic gene mutations and Crohn's disease; is there any association?
    Over-Hamzaoglu H; Abaci N; Türe F; Alkim C; Tezel A; Avsar E; Tözün N
    Hepatogastroenterology; 2005; 52(65):1467-9. PubMed ID: 16201098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
    Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
    Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population.
    Adamczuk Y; Iglesias Varela ML; Forastiero R; Martinuzzo M; Cerrato G; Pombo G; Carreras LO
    Thromb Haemost; 2000 Mar; 83(3):509-10. PubMed ID: 10744162
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.
    Törüner M; Erkan O; Soykan I; Bozdayi M; Cetinkaya H; Yurdaydin C; Uzunalimoğlu O; Ozden A
    Turk J Gastroenterol; 2004 Dec; 15(4):250-2. PubMed ID: 16249980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [[The importance of studying factor V Leiden and the 20210 [correction of 29210A] allele of the prothrombin gene in thromboembolic disease].
    Batlle J; López Fernández MF
    Sangre (Barc); 1999 Feb; 44(1):3-6. PubMed ID: 10323089
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid multiplex analysis for the factor V Leiden and prothrombin G20210A mutations associated with hereditary thrombophilia.
    Linfert DR; Rezuke WN; Tsongalis GJ
    Conn Med; 1998 Sep; 62(9):519-25. PubMed ID: 9785636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.